COWHEY THOMAS F.
Known title: SVP, Interim CFOCIK: 0001735242
Associated companies
Transaction History
| CVS | ▼ Sell | Tax Withholding | 3,203 | $218K | 4/1/2025 | View on chart |
| CVS | ▲ Buy | Grant | 16,181 | $1.1M | 4/1/2025 | View on chart |
| CVS | ▼ Sell | Tax Withholding | 5,318 | $349K | 2/28/2025 | View on chart |
| CVS | ▼ Sell | Tax Withholding | 1,719 | $137K | 4/1/2024 | View on chart |
| CVS | ▲ Buy | Grant | 15,082 | $0 | 4/1/2024 | View on chart |
| CVS | ▼ Sell | Tax Withholding | 5,641 | $424K | 2/28/2024 | View on chart |
| CVS | ▲ Buy | Grant | 7,358 | $500K | 11/30/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
CVS Health News: Caremark Shift, Settlement Deadline, Defensive Status
CVS Caremark is changing how patients access health services, according to a recent report. The company also faces a settlement claim deadline a month away, with guidance on how to receive the funds. Analysts note that CVS is among a few defensive healthcare stocks being watched as rates remain high, and it has recently outperformed market returns.
CVS Health News: Caremark Shift, Settlement Deadline, Defensive Status. CVS Caremark is changing how patients access health services, according to a recent report. The company also faces a settlement claim deadline a month away, with guidance on how to receive the funds. Analysts note that CVS is among a few defensive healthcare stocks being watched as rates remain high, and it has recently outperformed market returns.